SCHEMBL2833086

SCHEMBL2833086

CCN(CC)S(=O)(=O)c1ccccc1C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.58
MEN1 O00255 2/20 0.58
KDM4E B2RXH2 1/20 0.58
USP2 O75604 1/20 0.58
POLB P06746 1/20 0.58
CASP1 P29466 1/20 0.58
CASP7 P55210 1/20 0.58
HSD17B10 Q99714 1/20 0.58
CA12 O43570 5/20 0.54
CA9 Q16790 5/20 0.54
SMN1; SMN2 Q16637 2/20 0.51
TSHR P16473 1/20 0.51
TP53 P04637 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
GAA P10253 1/20 0.51
CYP2C9 P11712 1/20 0.51
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
MMP1 P03956 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30076512 0.91 CA12 (0.52) KMT2AMEN1KDM4EUSP2POLB
SCHEMBL3454762 0.87 CA12 (0.55) KMT2AMEN1KDM4EUSP2POLB
SCHEMBL14397821 0.87 KMT2A (0.47) KMT2AMEN1KDM4EUSP2POLB
SCHEMBL29941371 0.85 KMT2A (0.47) KMT2AMEN1KDM4EUSP2POLB
SCHEMBL30076519 0.85 CA12 (0.53) KMT2AMEN1KDM4EUSP2POLB
SCHEMBL11170567 0.84 KMT2A (0.56) KMT2AMEN1KDM4EUSP2POLB
SCHEMBL9210466 0.81 CA12 (0.53) KMT2AMEN1KDM4EUSP2POLB
SCHEMBL29385278 0.80 MCL1 (0.59) POLBCA12CA9SMN1; SMN2TSHR
SCHEMBL5515234 0.80 MCL1 (0.59) POLBCA12CA9SMN1; SMN2TSHR
SCHEMBL6112522 0.79 RAB9A (0.54) KMT2AMEN1POLBCA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010138955-A2 METHODS AND COMPOSITIONS FOR TREATING NEOPLASIA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-12-02 WO claimed
EP-0416499-A2 Benzoylguanidines, process for their preparation, their use as medicaments as well as medicament containing them HOECHST AKTIENGESELLSCHAFT (DE) 1991-03-13 EP disclosed